Gallacher Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $437K | Buy |
2,356
+1,274
| +118% | +$237K | 0.2% | 147 |
|
|
2025
Q1 | $227K | Sell |
1,082
-1,125
| -51% | -$236K | 0.11% | 240 |
|
|
2024
Q4 | $392K | Sell |
2,207
-34
| -2% | -$6.04K | 0.19% | 140 |
|
|
2024
Q3 | $443K | Sell |
2,241
-21
| -0.9% | -$4.15K | 0.2% | 124 |
|
|
2024
Q2 | $388K | Sell |
2,262
-45
| -2% | -$7.72K | 0.2% | 135 |
|
|
2024
Q1 | $420K | Sell |
2,307
-52
| -2% | -$9.47K | 0.21% | 121 |
|
|
2023
Q4 | $366K | Sell |
2,359
-209
| -8% | -$32.4K | 0.2% | 127 |
|
|
2023
Q3 | $383K | Buy |
2,568
+465
| +22% | +$69.3K | 0.24% | 96 |
|
|
2023
Q2 | $283K | Sell |
2,103
-29
| -1% | -$3.91K | 0.16% | 180 |
|
|
2023
Q1 | $340K | Buy |
2,132
+799
| +60% | +$127K | 0.2% | 134 |
|
|
2022
Q4 | $215K | Buy |
+1,333
| New | +$215K | 0.13% | 211 |
|